School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, People's Republic of China.
Department of Medicine and Geriatrics, Kwong Wah Hospital, 25 Waterloo Road, Kowloon, Hong Kong SAR, People's Republic of China.
BMC Nephrol. 2022 Jun 14;23(1):209. doi: 10.1186/s12882-022-02830-7.
Stage 5 chronic kidney disease (CKD) patients often experience decisional conflict when faced with the selection between the initiation of dialysis and conservative care. The study examined the effects of a brief hope intervention (BHI) on the levels of hope, decisional conflict and the quality of life for stage 5 CKD patients.
This is a single-blinded, randomized controlled trial (ClinicalTrials.gov identifier: NCT03378700). Eligible patients were recruited from the outpatient department renal clinic of a regional hospital. They were randomly assigned to either the intervention or the control group (intervention: n = 35; control: n = 37). All participants underwent a customized pre-dialysis education class, while the intervention group received also BHI. Data were collected prior to the intervention, immediately afterwards, and one month following the intervention. The Generalized Estimating Equation was used to measure the effects in the level of hope, decisional conflict scores (DCS) and Kidney Disease Quality of life (KDQOL-36) scores. Estimated marginal means and standard errors with 95% confidence intervals of these scores were also reported to examine the within group and between group changes.
An increase of the hope score was found from time 1 (29.7, 1.64) to time 3 (34.4, 1.27) in the intervention group. The intervention had a significant effect on the KDQOL-36 sub-scores Mental Component Summary (MCS) (Wald χ = 6.763, P = 0.009) and effects of kidney disease (Wald χ = 3.617, P = 0.004). There was a reduction in decisional conflict in both arms on the DCS total score (Wald χ = 7.885, P = 0.005), but the reduction was significantly greater in the control group (effect size 0.64).
The BHI appeared to increase the level of hope within the intervention arm. Nonetheless, differences across the intervention and control arms were not significant. The KDQOL-36 sub-scores on MCS and Effects of kidney disease were found to have increased and be higher in the intervention group. The DCS total score also showed that hope was associated with reducing decisional conflict.
ClinicalTrials.gov Protocol Registration, NCT03378700 . Registered July 12 2017.
5 期慢性肾脏病(CKD)患者在选择开始透析和保守治疗时经常面临决策冲突。本研究旨在探讨短期希望干预(BHI)对 5 期 CKD 患者的希望水平、决策冲突和生活质量的影响。
这是一项单盲、随机对照试验(ClinicalTrials.gov 标识符:NCT03378700)。合格的患者从一家地区医院的门诊肾诊所招募。他们被随机分配到干预组(n=35)或对照组(n=37)。所有参与者都接受了个性化的预透析教育课程,而干预组还接受了 BHI。在干预前、干预后即刻和干预后 1 个月收集数据。使用广义估计方程测量希望水平、决策冲突评分(DCS)和肾脏疾病生活质量(KDQOL-36)评分的效果。还报告了这些评分的估计边缘均值和 95%置信区间,以检查组内和组间的变化。
干预组的希望评分从第 1 时间点(29.7,1.64)增加到第 3 时间点(34.4,1.27)。干预对 KDQOL-36 子量表心理成分综合评分(MCS)(Wald χ=6.763,P=0.009)和肾脏疾病影响(Wald χ=3.617,P=0.004)有显著影响。在 DCS 总分方面,两组的决策冲突都有所减少(Wald χ=7.885,P=0.005),但对照组的减少更为显著(效应量 0.64)。
BHI 似乎在干预组中增加了希望水平。然而,干预组和对照组之间的差异没有统计学意义。干预组的 MCS 和肾脏疾病影响子量表的 KDQOL-36 评分升高,且更高。DCS 总分还表明,希望与降低决策冲突有关。
ClinicalTrials.gov 方案注册,NCT03378700。2017 年 7 月 12 日注册。